title: Studies on the acute lethality of diethylcarbamazine in the rat.
abstract: In spite of its effectiveness against microfilariae, very little is known about diethylcarbamazine's (DEC) therapeutic mechanism of action or the toxic sequelae which can result from overdose. In preliminary studies, a precipitous decrease in heart rate was noted in rats receiving 1000 mg DEC/kg ip. This effect was less pronounced at 750 mg/kg and was non-existent at 500 mg/kg. In the present study, attempts to attenuate DEC's cardiopulmonary insult by pretreating animals with cyproheptadine failed. Atropine pretreatment failed to block the negative chronotropic effects of DEC, but did restore respiratory function and reduce the lethality associated with the drug. Biochemical studies showed that ATP:ADP ratios in the hearts from rats given high dosages of DEC were elevated over those in controls (11:1 versus 5:1). Inosine levels decreased in cardiac tissues taken from DEC-treated rats. Subsequent enzyme studies revealed that DEC has a potent inhibitory effect on calcium-dependent ATPases from a variety of tissues. Taken together, our data indicate that the mode of acute DEC-lethality involves cardiopulmonary suppression. Furthermore, the cardiac depressant effect of DEC appears related to inhibition of calcium ATPases in cardiac myocytes. To our knowledge, this is the first report of ATPase sensitivity to DEC, a finding that has interesting toxicologic and pharmacologic ramifications.
authors.affiliation: Department of Biological Sciences, Samford University, Birmingham, AL 35229.
authors.forename: R N
authors.initials: RN
authors.lastname: Hunsinger
authors.forename: R L
authors.initials: RL
authors.lastname: Jenkins
authors.forename: A L
authors.initials: AL
authors.lastname: Brown
authors.forename: D H
authors.initials: DH
authors.lastname: Belew
mesh_terms: D000244:Adenosine Diphosphate / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D001285:Atropine / Q000494:pharmacology*; D000252:Calcium-Transporting ATPases / Q000187:drug effects* / Q000378:metabolism; D003533:Cyproheptadine / Q000494:pharmacology*; D004049:Diethylcarbamazine / Q000037:antagonists & inhibitors / Q000633:toxicity*; D006339:Heart Rate / Q000187:drug effects*; D009206:Myocardium / Q000737:chemistry / Q000201:enzymology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012119:Respiration / Q000187:drug effects*
chemical_list: D003533:Cyproheptadine; D000244:Adenosine Diphosphate; D001285:Atropine; D000255:Adenosine Triphosphate; D000252:Calcium-Transporting ATPases; D004049:Diethylcarbamazine